A Novel Function of Novobiocin: Disrupting the Interaction of HIF 1α and p300/CBP through Direct Binding to the HIF1α C-Terminal Activation Domain
Open Access
- 6 May 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (5) , e62014
Abstract
Hypoxia-inducible factor 1α (HIF1α) is an important cellular survival protein under hypoxic conditions, regulating the cellular response to low oxygen tension via recruitment of a transcriptional co-activator, p300/CBP. p300/CBP induces expression of multiple genes involved in cell survival, proliferation, angiogenesis, and tumor development. Thus, a strategy to inhibit hypoxic responses in tumors may be to target the protein-protein interaction between HIF1α and p300/CBP. Here, we document, for the first time, that the aminocoumarin antibiotic, novobiocin, directly blocks the protein-protein interaction between the HIF1α C-terminal activation domain (CTAD) and the cysteine-histidine rich (CH1) region of p300/CBP. Also, novobiocin down-regulated HIF1α-controlled gene expression, specifically CA9, which is related to tumorigenesis. In a monolayer cell culture, novobiocin inhibited cell proliferation and colony formation in the MCF-7 human breast adenocarcinoma cell line and the A549 human lung cancer cell line. Rescue experiments revealed that the recombinant CTAD fragment of HIF1α partially reversed novobiocin’s inhibitory effects on cell proliferation and colony formation in MCF-7 cells. These findings suggest a novel mechanism of action for novobiocin which has the potential for innovative therapeutic use in tumor treatment.Keywords
This publication has 40 references indexed in Scilit:
- Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancerBreast Cancer Research, 2012
- Synthesis and biological evaluation of arylated novobiocin analogs as Hsp90 inhibitorsBioorganic & Medicinal Chemistry Letters, 2011
- HIF-1α effects on angiogenic potential in human small cell lung carcinomaJournal of Experimental & Clinical Cancer Research, 2011
- Carbonic anhydrase 9 in clear cell renal cell carcinoma: A marker for diagnosis, prognosis and treatmentEuropean Journal of Cancer, 2010
- Inhibition of hypoxia‐inducible transcription factor complex with designed epipolythiodiketopiperazineBiopolymers, 2010
- Translesion DNA synthesis polymerases in DNA interstrand crosslink repairEnvironmental and Molecular Mutagenesis, 2010
- Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancerBritish Journal of Cancer, 2009
- Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancerBritish Journal of Cancer, 2007
- Amphotericin B blunts erythropoietin response to hypoxia by reinforcing FIH-mediated repression of HIF-1Blood, 2006
- The role of carbonic anhydrase IX overexpression in kidney cancerEuropean Journal of Cancer, 2005